首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
Authors:Abhijeet Waghray  Bengi Balci  Galal El‐Gazzaz  Richard Kim  Robert Pelley  KV Narayanan Menon  Bassam Estfan  Carlos Romero‐Marrero  Federico Aucejo
Affiliation:1. Hepatobiliary and Liver Transplant Surgery, Cleveland Clinic Foundation, , Cleveland, OH, USA;2. Gastroenterology Oncology, H. Lee Moffitt Cancer Center and Research Institute, , Tampa, FL, USA;3. Solid Tumor Oncology, Cleveland Clinic Foundation, , Cleveland, OH, USA;4. Gastroenterology and Hepatology, Cleveland Clinic Foundation, , Cleveland, OH, USA
Abstract:
Keywords:hepatocellular carcinoma  liver transplantation     MELD     Milan criteria  sorafenib
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号